|
|
Volumn 17, Issue 3, 1998, Pages 219-227
|
|
Dermatologic lupus: Hopkins Lupus Cohort
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIMALARIAL AGENT;
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
DAPSONE;
METHOTREXATE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RETINOID;
SUNSCREEN;
THALIDOMIDE;
ANTIPHOSPHOLIPID SYNDROME;
CLINICAL FEATURE;
DISEASE COURSE;
HUMAN;
MORBIDITY;
PROTECTIVE EQUIPMENT;
REVIEW;
SKIN MANIFESTATION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ADULT;
ANTIBODIES, ANTIPHOSPHOLIPID;
ANTIPHOSPHOLIPID SYNDROME;
BALTIMORE;
COHORT STUDIES;
DISEASE PROGRESSION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LUPUS ERYTHEMATOSUS, CUTANEOUS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
PROGNOSIS;
PROSPECTIVE STUDIES;
QUALITY OF LIFE;
|
|
EID: 0031720416
PISSN: 10855629
EISSN: None
Source Type: Journal
DOI: 10.1016/S1085-5629(98)80017-5 Document Type: Review |
|
Times cited : (17)
|
|
References (58)
|
